Finance

Lists
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
15,83 US$
-0,75%
(-0,12) 1D
15,83 US$
0,00% (0,00)
After hours
Closed: 2 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
16,06 US$
High
16,06 US$
Low
15,74 US$
Mkt. cap
2,11 მლრდ.
Avg. vol.
882,88 ათ.
Volume
813,42 ათ.
P/E ratio
6,91
52-wk high
19,25 US$
52-wk low
10,92 US$
EPS
2,29 US$
Beta
1,60
Shares outstanding
133,05 მლნ.
No. of employees
128
Open
16,06 US$
High
16,06 US$
Low
15,74 US$
Mkt. cap
2,11 მლრდ.
Avg. vol.
882,88 ათ.
Volume
813,42 ათ.
P/E ratio
6,91
52-wk high
19,25 US$
52-wk low
10,92 US$
EPS
2,29 US$
Beta
1,60
Shares outstanding
133,05 მლნ.
No. of employees
128
News stories
From web sources and news partners
About Aurinia Pharmaceuticals Inc
CEO-
Employees128
Founded2012
Headquartersედმონტონი, ალბერტა, კანადა
Sector-
Websiteauriniapharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to AUPH in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AUPH in the last 3 months.
Highest
Current 15,83 US$
21,00 US$ (+32,66%)
Average
18,00 US$ (+13,71%)
Lowest
16,00 US$ (+1,07%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Martin PhD
Bloom Burton
Buy
Upgraded
21,00 US$
+32,7%
08/20/2026
Stacy Ku
TD Cowen
Buy
Maintained
17,00 US$
+7,4%
08/19/2026
Douglas Miehm
RBC Capital
Hold
Maintained
16,00 US$
+1,1%
08/07/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
17,00 US$
+7,4%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
73,47 მლნ.
77,11 მლნ.
77,70 მლნ.
83,22 მლნ.
Cost of goods sold
8,50 მლნ.
40,55 მლნ.
13,98 მლნ.
18,30 მლნ.
Cost of revenue
8,50 მლნ.
40,55 მლნ.
13,98 მლნ.
18,30 მლნ.
Research and development expenses
8,11 მლნ.
-20,86 მლნ.
-
1,31 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,18 მლნ.
29,26 მლნ.
22,03 მლნ.
23,51 მლნ.
Operating expense
35,22 მლნ.
-6,37 მლნ.
22,31 მლნ.
18,58 მლნ.
Total operating expenses
43,72 მლნ.
34,18 მლნ.
36,28 მლნ.
36,88 მლნ.
Operating income
29,74 მლნ.
42,94 მლნ.
41,42 მლნ.
46,34 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
31,96 მლნ.
35,69 მლნ.
43,92 მლნ.
48,79 მლნ.
EBT excluding unusual items
31,96 მლნ.
35,69 მლნ.
43,92 მლნ.
48,79 მლნ.
Income tax expense
411,00 ათ.
-175,10 მლნ.
9,57 მლნ.
11,37 მლნ.
Effective tax rate
1,29%
-490,62%
21,79%
23,31%
Other operating expenses
929,00 ათ.
-14,77 მლნ.
279,00 ათ.
-6,23 მლნ.
Net income
31,55 მლნ.
210,79 მლნ.
34,36 მლნ.
37,41 მლნ.
Net profit margin
42,95%
273,35%
44,21%
44,96%
Earnings per share
0,23
1,53
0,25
0,28
Interest and investment income
3,32 მლნ.
3,50 მლნ.
3,52 მლნ.
3,39 მლნ.
Interest expense
-1,10 მლნ.
-1,05 მლნ.
-1,01 მლნ.
-948,00 ათ.
Net interest expenses
2,22 მლნ.
2,45 მლნ.
2,50 მლნ.
2,44 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
34,61 მლნ.
47,80 მლნ.
46,24 მლნ.
51,18 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები